So near yet so far: why won’t the UK prescribe medical cannabis?

This Drug Science research was published in the British Medical Journal Open, you can download the full report here. In November 2018 when the UK made cannabis-based products for medicinal use (CBPMs) legal most people assumed these would immediately be made available to patients, but they were wrong. In the year since almost no National  …


Medical cannabis in the UK: From principle to practice

Read the full paper here (open access) Drug Science submits it’s finding concerning the UK Medical cannabis industry. In our recent peer-reviewed publication, Drug Science examines the current barriers to prescribing medical cannabis; ethical issues that arise from that process and we present our recommendations for best practice within this space. In the UK, medical  …


Twenty21 is now live

About Project Twenty21 Project Twenty21 is a registry aiming to monitor the health outcomes of 20,000 patients using cannabis based medicinal products (CBMPs), creating the largest body of evidence in Europe for the safety and efficacy of CBMPs. Drug Science hope that the findings of Project Twenty21 will provide evidence for NHS funding where the  …


Prescribed CBD could help people quit cannabis

A benchmark clinical trial published today shows that cannabidiol (CBD) could be a safe and effective treatment for problematic cannabis use.  Results from the first-ever randomised clinical trial of CBD for cannabis use disorder suggests that prescribed doses of the non-intoxicating constituent part of the cannabis plant could help people kick the habit. In the  …